Opicapone | Radio Compass News | PharmaCompass.com

Grow Your Pharma Business Digitally

X

Market Place

Sourcing support

Sourcing Support

Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

All News Opicapone

Amneal and BIAL Announce U.S. Licensing Agreement for ONGENTYS® (opicapone)

07 Dec 2023 //

BUSINESSWIRE

Neurocrine Presents Parkinson`s Disease Patient Characteristics From ONGENTYS

24 Oct 2022 //

PRNEWSWIRE

Neurocrine Presents Analysis of ONGENTYS Capsules Effect on COMT Activity

15 Sep 2022 //

PRNEWSWIRE

Bial Portela & Companhia Ontilyv (opicapone) Receives Approval in Europe

07 Mar 2022 //

EMA

Bial Portela`s Biologic Optilyv (Opicapone) Receives Approval in Europe

07 Mar 2022 //

EMA

New study investigating impact of ONGENTYS at the MDS Virtual Congress 2021

14 Sep 2021 //

PHARMIWEB

BIAL and Recipharm expand long-term supply agreement for opicapone API

01 Oct 2020 //

PRESS RELEASE

Neurocrine Announces Once-Daily ONGENTYS (opicapone) Now Available in the U.S.

14 Sep 2020 //

PRNEWSWIRE

Neurocrine Biosciences Presents Data Demonstrating Efficacy of Approved ONGENTYS

11 Sep 2020 //

PRNNEWSWIRE